Results indicated that FOXD3-AS1 knockdown exerts antitumor effect in NPC via regulating miR-135a-5p, which will provide further understanding of the molecular mechanisms and therapeutic strategies for NPC treatment. The gene discussed is FOXD3; the disease is nasopharyngeal carcinoma.